Literature DB >> 25448999

Retinal detachment associated with AIDS-related cytomegalovirus retinitis: risk factors in a resource-limited setting.

Michael Yen1, Jenny Chen2, Somsanguan Ausayakhun3, Paradee Kunavisarut3, Pornpattana Vichitvejpaisal3, Sakarin Ausayakhun3, Choeng Jirawison4, Jessica Shantha5, Gary N Holland6, David Heiden7, Todd P Margolis8, Jeremy D Keenan9.   

Abstract

PURPOSE: To determine risk factors predictive of retinal detachment in patients with cytomegalovirus (CMV) retinitis in a setting with limited access to ophthalmic care.
DESIGN: Case-control study.
METHODS: Sixty-four patients with CMV retinitis and retinal detachment were identified from the Ocular Infectious Diseases and Retina Clinics at Chiang Mai University. Three control patients with CMV retinitis but no retinal detachment were selected for each case, matched by calendar date. The medical records of each patient were reviewed, with patient-level and eye-level features recorded for the clinic visit used to match cases and controls, and also for the initial clinic visit at which CMV retinitis was diagnosed. Risk factors for retinal detachment were assessed separately for each of these time points using multivariate conditional logistic regression models that included 1 eye from each patient.
RESULTS: Patients with a retinal detachment were more likely than controls to have low visual acuity (odds ratio [OR], 1.24 per line of worse vision on the logMAR scale; 95% confidence interval [CI], 1.16-1.33) and bilateral disease (OR, 2.12; 95% CI, 0.92-4.90). Features present at the time of the initial diagnosis of CMV retinitis that predicted subsequent retinal detachment included bilateral disease (OR, 2.68; 95% CI, 1.18-6.08) and lesion size (OR, 2.64 per 10% increase in lesion size; 95% CI, 1.41-4.94).
CONCLUSION: Bilateral CMV retinitis and larger lesion sizes, each of which is a marker of advanced disease, were associated with subsequent retinal detachment. Earlier detection and treatment may reduce the likelihood that patients with CMV retinitis develop a retinal detachment.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25448999      PMCID: PMC4262697          DOI: 10.1016/j.ajo.2014.10.014

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  45 in total

1.  The number of ophthalmologists in practice and training worldwide: a growing gap despite more than 200,000 practitioners.

Authors:  Serge Resnikoff; William Felch; Tina-Marie Gauthier; Bruce Spivey
Journal:  Br J Ophthalmol       Date:  2012-03-26       Impact factor: 4.638

2.  Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U).

Authors:  J Orellana; S A Teich; A H Friedman; F Lerebours; J Winterkorn; D Mildvan
Journal:  Ophthalmology       Date:  1987-07       Impact factor: 12.079

3.  Treatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovir.

Authors:  Somsanguan Ausayakhun; Prapa Yuvaves; Suphop Ngamtiphakom; Jeradech Prasitsilp
Journal:  J Med Assoc Thai       Date:  2005-11

4.  Prophylactic argon laser coagulation for rhegmatogenous retinal detachment in AIDS patients with cytomegalovirus retinitis.

Authors:  C Althaus; K U Loeffler; M Schimkat; T Hudde; R Sundmacher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-05       Impact factor: 3.117

5.  The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.

Authors:  D A Wohl; M A Kendall; S Owens; G Holland; M Nokta; S A Spector; R Schrier; S Fiscus; M Davis; M A Jacobson; J S Currier; K Squires; B Alston-Smith; J Andersen; W R Freeman; M Higgins; F J Torriani
Journal:  HIV Clin Trials       Date:  2005 May-Jun

6.  Causes of visual acuity loss among HIV-infected patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy in Chiang Mai University Hospital.

Authors:  Chulaluck Tangmonkongvoragul; Somsanguan Ausayakhun
Journal:  J Med Assoc Thai       Date:  2012-04

7.  Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).

Authors:  Gary N Holland; Jean D Vaudaux; Kevin M Shiramizu; Fei Yu; David T Goldenberg; Anurag Gupta; Margrit Carlson; Russell W Read; Roger D Novack; Baruch D Kuppermann
Journal:  Am J Ophthalmol       Date:  2008-01       Impact factor: 5.258

8.  Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001.

Authors:  I Yust; Z Fox; M Burke; A Johnson; D Turner; A Mocroft; C Katlama; B Ledergerber; P Reiss; O Kirk
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-30       Impact factor: 3.267

Review 9.  Local therapy for cytomegalovirus retinopathy.

Authors:  R E Engstrom; G N Holland
Journal:  Am J Ophthalmol       Date:  1995-09       Impact factor: 5.258

10.  Telemedicine diagnosis of cytomegalovirus retinitis by nonophthalmologists.

Authors:  Michael Yen; Somsanguan Ausayakhun; Jenny Chen; Sakarin Ausayakhun; Choeng Jirawison; David Heiden; Gary N Holland; Todd P Margolis; Jeremy D Keenan
Journal:  JAMA Ophthalmol       Date:  2014-09       Impact factor: 7.389

View more
  6 in total

1.  The human cytomegalovirus lytic cycle is induced by 1,25-dihydroxyvitamin D3 in peripheral blood monocytes and in the THP-1 monocytic cell line.

Authors:  Shu-En Wu; William E Miller
Journal:  Virology       Date:  2015-05-15       Impact factor: 3.616

Review 2.  Ophthalmologic Disease in HIV Infection: Recent Changes in Pathophysiology and Treatment.

Authors:  Michael W Stewart
Journal:  Curr Infect Dis Rep       Date:  2017-10-19       Impact factor: 3.725

3.  A role for 3-O-sulfated heparan sulfate in promoting human cytomegalovirus infection in human iris cells.

Authors:  John Baldwin; Erika Maus; Brian Zanotti; Michael V Volin; Ritesh Tandon; Deepak Shukla; Vaibhav Tiwari
Journal:  J Virol       Date:  2015-02-25       Impact factor: 5.103

4.  Cytomegalovirus retinitis in the highly active anti-retroviral therapy era.

Authors:  Ifeoma N Ude; Steven Yeh; Jessica G Shantha
Journal:  Ann Eye Sci       Date:  2022-03

5.  Do we need separate screening strategies for cytomegalovirus retinitis in different underlying immunosuppressed states? A retrospective study from Western India.

Authors:  Bindiya Doshi; Niha Z Khatib; Sumita Phatak; Rohit Modi; Sarvesh Tiwari; Anand Subramanyam
Journal:  Indian J Ophthalmol       Date:  2021-03       Impact factor: 1.848

6.  Socioeconomic disadvantage and impact on visual outcomes in patients with viral retinitis and retinal detachment.

Authors:  Ashley Zhou; Sally S Ong; Ishrat Ahmed; J Fernando Arevalo; Cindy X Cai; James T Handa
Journal:  J Ophthalmic Inflamm Infect       Date:  2022-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.